NON-HODGKIN LYMPHOMA
Clinical trials for NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test exercise as Anti-Aging treatment for cancer survivors
Disease control Not yet recruitingThis study aims to see if exercise and behavioral coaching can slow down accelerated aging in older adults who have survived blood cancers like leukemia and lymphoma. Researchers will enroll 180 participants aged 50+ and randomly assign them to different exercise programs to meas…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New immune cell attack tested for tough blood cancers
Disease control Not yet recruitingThis early-stage study is testing the safety of a new combination treatment for people with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment adds an experimental therapy—'natural killer' (NK) immune cells from a donor—…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Could a Donor's workout help beat leukemia? new trial tests Exercise-Powered cells
Disease control Not yet recruitingThis is a first-in-human study to see if a new type of donor cell treatment is safe and might work better than the standard. The new treatment uses immune cells collected from a related donor after they exercise, with the idea that exercise makes these 'natural killer' cells more…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: University of Arizona • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Your voice could warn of dangerous brain swelling during cancer treatment
Knowledge-focused Not yet recruitingThis study aims to find out if simple voice recordings from a smartphone can help detect a serious brain side effect called ICANS in patients receiving CAR T-cell therapy for lymphoma or multiple myeloma. Researchers will collect voice recordings and daily brain function assessme…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:08 UTC